Viewing Study NCT06259747



Ignite Creation Date: 2024-05-06 @ 8:06 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06259747
Status: COMPLETED
Last Update Posted: 2024-02-16
First Post: 2024-02-07

Brief Title: Therapeutic Implications of Acutaping on Nausea and Vomiting During Pregnancy
Sponsor: Kafrelsheikh University
Organization: Kafrelsheikh University

Study Overview

Official Title: Potential Therapeutic Implications of Acutaping on Nausea and Vomiting During Pregnancy
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will answer the following research question

Is acutaping has therapeutic implications on symptoms of nausea and vomiting during pregnancy
Detailed Description: Nausea and vomiting during pregnancy NVP are common symptoms with prevalence rate from 50 to 90 NVP symptoms often appear between weeks 5 and 6 peak at 8 to 9 weeks and subside between weeks 16 and 20 Long-term morning sickness during pregnancy increases the incidence of postpartum depression symptoms in women and severe NVP increases the chance of low birth weight

NVP is multifactorial and the most common causes potentially including hormone imbalances placental disorders and genetic causes Genetic factors Evidence in support of a genetic predisposition to nausea and vomiting of pregnancy includes the following a the concordance in frequency of nausea and vomiting of pregnancy in monozygotic twins b the finding that siblings and mothers of patients affected with nausea and vomiting of pregnancy are more likely to be affected than relatives of unaffected individuals c the variation in frequency between ethnic groups d the higher frequency of nausea and vomiting of pregnancy in patients with predisposing conditions that are genetically determined such as taste sensation and e the occurrence of nausea and vomiting of pregnancy in women with inherited glycoprotein hormone receptor defects

The fundamental stimulus-a placental product the triggering factor for nausea and vomiting of pregnancy has not been identified although human chorionic gonadotropin and estrogens have been implicated The principle reason for considering human chorionic gonadotropin initially was the close temporal association between peak human chorionic gonadotropin concentrations and peak nausea and vomiting of pregnancy symptoms Conditions associated with higher human chorionic gonadotropin production are associated with nausea and vomiting of pregnancy These include multiple gestation with hyperemesis gravidarum 4 to 5 times more common than in singletons

Whatever the specific trigger the emetic response is fundamentally the same there is a marked reduction in gastric tone and motility followed by a retrograde giant contraction moving small intestinal contents into the stomach Thereafter contractions of the diaphragm and abdominal muscles combine with relaxation of the gastroesophageal sphincter to facilitate passage of gastrointestinal contents

Although there are several pharmacological treatments for NVP many medical professionals and expectant mothers prefer non-pharmacological therapy over pharmacological ones because of worry for their impact on foetal outcomes

For years traditional Chinese acupuncture has been promoted as a helpful antiemetic An alternative treatment for preventing nausea and vomiting is acupressure

Kinesio tape is an elastic therapeutic tape that is drug free and used to treat a range of musculoskeletal issues including dysfunction pain and injury and a variety of other disorders When compared to normal drugs alone kinesio taping on the stomach area is more successful at relieving nausea and vomiting in emesis gravidarum patients

In acutaping acupressureacupuncture and kinesio taping are used to treat internal and gynecological issues like nausea and vomiting during pregnancy by stimulating acupressure points with kinesio tape

Nausea and vomiting of pregnancy is a very common disorder reported in 70-80 of all pregnant women The extent of vomiting may be so profound that weight loss electrolyte imbalance and dehydration requiring hospitalisation result Women with nausea and vomiting during pregnancy and nausea only during pregnancy had proteinuria and preeclampsia than the symptom free women NVP also has a significant detrimental impact on quality of life QoL especially affecting physical QoL and work function This impact is evident across the spectrum of NVP but significantly worse with more severe symptoms

Studies have repeatedly shown that there is a high perception of teratogenic risk among pregnant and planning women regarding medication use in pregnancy and that this is also true for NVP which is experienced by the vast majority of pregnant women

There are many studies using acustimulation on nausea and vomiting in pregnant women including acupressure acupuncture and electrical stimulationThe stimulation of this point can also be done by dry cupping and also auriculotherapy used for NVP

There is no study about the potential therapeutic implication of acutaping on nausea and vomiting during pregnancy so our study will be used to detect this therapeutic implication of acutaping

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None